Clinical trial
Induction-maintenance of Lopinavir/r in HIV-infected Subjects
NCT00159224 · Fundación Huésped, Other · Completed
Key facts
| NCT number | NCT00159224 |
|---|---|
| Title | Induction-maintenance of Lopinavir/r in HIV-infected Subjects |
| Official title | Study ACA-ARGE-04-001 "A Pilot, Open-Label Study Assessing Safety, Tolerability, Efficacy of a Simplified Lopinavir/Ritonavir Induction/Maintenance Therapy in HIV-Infected Subjects on Their First Protease Inhibitor-Based Regimen". |
| Lead sponsor | Fundación Huésped, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Lopinavir/ritonavir simplification strategy |
| Enrollment | 100 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 7, 2015 |
| Countries | Argentina, Canada, Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: